1. Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection
- Author
-
Milighetti, M, Peng, Y, Tan, C, Mark, M, Nageswaran, G, Byrne, S, Ronel, T, Peacock, T, Mayer, A, Chandran, A, Rosenheim, J, Whelan, M, Yao, X, Liu, G, Felce, SL, Dong, T, Mentzer, AJ, Knight, JC, Balloux, F, Greenstein, E, Reich-Zeliger, S, Pade, C, Gibbons, JM, Semper, A, Brooks, T, Otter, A, Altmann, DM, Boyton, RJ, Maini, MK, McKnight, A, Manisty, C, Treibel, TA, Moon, JC, COVIDsortium Investigators, Noursadeghi, M, and Chain, B
- Subjects
Multidisciplinary - Abstract
T cell responses precede antibody and may provide early control of infection. We analyzed the clonal basis of this rapid response following SARS-COV-2 infection. We applied T cell receptor (TCR) sequencing to define the trajectories of individual T cell clones immediately. In SARS-COV-2 PCR+ individuals, a wave of TCRs strongly but transiently expand, frequently peaking the same week as the first positive PCR test. These expanding TCR CDR3s were enriched for sequences functionally annotated as SARS-COV-2 specific. Epitopes recognized by the expanding TCRs were highly conserved between SARS-COV-2 strains but not with circulating human coronaviruses. Many expanding CDR3s were present at high frequency in pre-pandemic repertoires. Early response TCRs specific for lymphocytic choriomeningitis virus epitopes were also found at high frequency in the preinfection naive repertoire. High-frequency naive precursors may allow the T cell response to respond rapidly during the crucial early phases of acute viral infection.
- Published
- 2023
- Full Text
- View/download PDF